Solid Biosciences Inc (NASDAQ:SLDB) has a beta value of 2.07 and has seen 0.54 million shares traded in the recent trading session. The company, currently valued at $285.17M, closed the recent trade at $3.68 per share which meant it lost -$0.02 on the day or -0.54% during that session. The SLDB stock price is -266.03% off its 52-week high price of $13.47 and 21.74% above the 52-week low of $2.88. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.13 million shares traded. The 3-month trading volume is 2.46 million shares.
The consensus among analysts is that Solid Biosciences Inc (SLDB) is Buy stock at the moment, with a recommendation rating of 1.08. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.54.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Sporting -0.54% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SLDB stock price touched $3.68 or saw a rise of 17.86%. Year-to-date, Solid Biosciences Inc shares have moved -8.00%, while the 5-day performance has seen it change -18.04%. Over the past 30 days, the shares of Solid Biosciences Inc (NASDAQ:SLDB) have changed -28.12%. Short interest in the company has seen 7.84 million shares shorted with days to cover at 1.39.
Wall Street analysts have a consensus price target for the stock at $19, which means that the shares’ value could jump 80.63% from the levels at last check today. The projected low price target is $12.0 while the price target rests at a high of $20.0. In that case, then, we find that the latest price level in today’s session is -443.48% off the targeted high while a plunge would see the stock gain -226.09% from the levels at last check today.
Solid Biosciences Inc (SLDB) estimates and forecasts
The company’s shares have lost -47.88% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 41.25% over the past 5 years. Earnings growth for 2025 is a modest 28.29% while over the next 5 years, the company’s earnings are expected to increase by 18.18%.
SLDB Dividends
Solid Biosciences Inc is expected to release its next earnings report on 2025-Mar-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders own 0.70% of the company shares, while shares held by institutions stand at 62.23% with a share float percentage of 62.67%. Investors are also buoyed by the number of investors in a company, with Solid Biosciences Inc having a total of 128.0 institutions that hold shares in the company. The top two institutional holders are PERCEPTIVE ADVISORS LLC with over 6.91 million shares worth more than $39.16 million. As of 2024-06-30, PERCEPTIVE ADVISORS LLC held 16.8725% of shares outstanding.
The other major institutional holder is RA CAPITAL MANAGEMENT, L.P., with the holding of over 4.33 million shares as of 2024-06-30. The firm’s total holdings are worth over $24.55 million and represent 10.579% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 1.10% shares in the company for having 854.68 shares of worth $3.12 million while later fund manager owns 597.6 shares of worth $2.18 million as of Feb 28, 2025, which makes it owner of about 0.77% of company’s outstanding stock.
